Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention

Circulation Journal

Volumn 75, Issue 11, 2011, Pages 2648-2653

  Jaberg, Laurenz ^a   Toggweiler, Stefan ^a   Puck, Marietta ^a   Frank, Michelle ^a   Rufibach, Kaspar ^b   Lüscher, Thomas F ^a   Corti, Roberto ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Acute coronary syndrome; Biomarker; Left main disease; Mortality; Outcome

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KILLIP CLASS; LEFT CORONARY ARTERY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TIME FACTORS;

EID: 80054880069     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0095     Document Type: Article

References (30)

1. Ellis SG, Tamai H, Nobuyoshi M, Kosuga K, Colombo A, Holmes DR, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: Initial results from a multicenter registry analysis 1994-1996. Circulation 1997; 96: 3867-3872.
2. Cheng CI, Lee FY, Chang JP, Hsueh SK, Hsieh YK, Fang CY, et al. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: Coronary stenting vs coronary artery bypass grafting. Circ J 2009; 73: 705-712.
3. Wong SC, Sanborn T, Sleeper LA, Webb JG, Pilchik R, Hart D, et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK Trial Registry: Should we emergently revascularize Occluded Coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1077.
4. Montalescot G, Brieger D, Eagle KA, Anderson FA Jr, FitzGerald G, Lee MS, et al; GRACE Investigators. Unprotected left main revascularisation in patients with acute coronary syndromes. Eur Heart J 2009; 30: 2308-2317.
5. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, et al; for the Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators. The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am J Cardiol 2009; 158: 193-201.
6. Corti R, Toggweiler S. PCI in acute left main disease: A paradigm shift or a new reality? Eur Heart J 2009; 30: 2295-2296.
7. Yasuda S, Shimokawa H. Acute myocardial infarction: The enduring challenge for cardiac protection and survival. Circ J 2009; 73: 2000-2008.
8. Toggweiler S, Borst O, Enseleit F, Hermann M, Ruschitzka F, Lüscher TF, et al. NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings. Clin Cardiol 2011; 34: 183-188.
9. Sakuma M, Nakamura M, Tanaka F, Onoda T, Itai K, Tanno K, et al. Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population. Circ J 2010; 74: 792-797.
10. De Lemos JA, Morrow DA, Bentley JH. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
11. Galasko GIW, Lahiri A, Barnes SC, Collinson P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005; 26: 2269-2276.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
13. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
14. Mottram PM, Leano R, Marwick TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol 2003; 92: 1434-1438.
15. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: A novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005; 26: 234-240.
16. Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer ME, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 2006; 151: 1223-1230.
17. Arakawa N, Nakamura M, Aoki H, Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 1994; 85: 334-340.
18. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929.
19. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913-2918.
20. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108: 275-281.
21. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, et al; on behalf of the Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004; 110: 128-134.
22. Bassan R, Tura BR, Maisel AS. B-type natriuretic peptide: A strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department. Coronary Artery Disease 2009; 20: 143-149.
23. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 284-287.
24. Khan SQ, Quinn P, Davies JE, Ng LL. N-terminal pro-B-type natriuretic peptide is better than TIMI score at predicting death following acute myocardial infarction. Heart 2008; 94: 40-43.
25. Lorgis L, Zeller M, Dentan G, Sicard P, Buffet P, L'Huillier I, et al; RICO Survey Working Group. Prognostic value of N-terminal probrain natriuretic peptide in elderly people with acute myocardial infarction: Prospective observational study. BMJ 2009; 338: b1605.
26. Navarro Estrada JL, Rubinstein F, Bahit MC, Rolandi F, Perez de Arenaza D, Gabay JM, et al; PACS Investigators. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Am Heart J 2006; 151: 1093. e1-e7.
27. Palazzuoli A, Gennari L, Calabria P, Quatrini I, Vecchiato L, De Paola V, et al. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol 2005; 96: 1705-1710.
28. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PM, Morrow DA, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44: 564-568.
29. Morrow DA, de Lemos JA, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, et al; A to Z Investigators. Prognostic value of serial Btype natriuretic peptide during follow-up of patients with unstable coronary artery disease. JAMA 2005; 294: 2866-2871.
30. Ang DS, Kong CF, Kao MP, Struthers AD. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Am Heart J 2009; 158: 133-140.